Natural Capsules Ltd
NATCAPSUQNatural Capsules Ltd
NATCAPSUQ
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 71.28 | 1.35 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.27 | 6.55 | 0.51% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Natural Capsules Limited makes hard gelatin capsule shells, hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 55.57 | 60.92 | 62.50 | 82.42 | 136.08 | 172.94 | 157.36 | 158.85 | ||||||||
Raw Materials | 23.54 | 22.80 | 27.92 | 36.10 | 57.99 | 83.86 | 85.48 | 138.59 | ||||||||
| Power & Fuel Cost | 6.79 | 8.89 | 8.16 | 8.51 | 11.90 | 13.75 | 15.19 | |||||||||
| Employee Cost | 5.23 | 5.57 | 5.91 | 6.97 | 8.48 | 9.51 | 11.00 | |||||||||
| Selling & Administrative Expenses | 9.47 | 8.89 | 8.99 | 9.76 | 16.95 | 23.00 | 17.80 | |||||||||
| Operating & Other expenses | 4.19 | 8.97 | 5.13 | 7.08 | 14.25 | 6.89 | 5.89 | |||||||||
EBITDA | 6.35 | 5.80 | 6.39 | 14.00 | 26.51 | 35.93 | 22.00 | 20.26 | ||||||||
| Depreciation/Amortization | 4.33 | 3.20 | 4.12 | 4.31 | 5.04 | 7.21 | 8.67 | 8.84 | ||||||||
| PBIT | 2.02 | 2.60 | 2.27 | 9.69 | 21.47 | 28.72 | 13.33 | 11.42 | ||||||||
| Interest & Other Items | 0.33 | 0.53 | 0.91 | 0.54 | 2.08 | 3.73 | 5.27 | 5.29 | ||||||||
| PBT | 1.69 | 2.07 | 1.36 | 9.15 | 19.39 | 24.99 | 8.06 | 6.13 | ||||||||
| Taxes & Other Items | 0.57 | 0.14 | 0.52 | 2.24 | 5.47 | 6.55 | 2.50 | 1.79 | ||||||||
| Net Income | 1.12 | 1.93 | 0.84 | 6.91 | 13.92 | 18.44 | 5.56 | 4.34 | ||||||||
| EPS | 1.47 | 2.54 | 1.11 | 9.09 | 19.05 | 22.64 | 5.97 | 4.64 | ||||||||
| DPS | 0.82 | 0.82 | 0.49 | 0.82 | 1.00 | 1.00 | 0.00 | 1.00 | ||||||||
| Payout ratio | 0.56 | 0.32 | 0.45 | 0.09 | 0.05 | 0.04 | 0.00 | 0.22 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Natural Capsules Ltd | 55.64 | 1.35 | — |
| Sun Pharmaceutical Industries Ltd | 45.34 | 6.47 | 0.75% |
| Cipla Ltd | 31.21 | 4.80 | 0.82% |
| Torrent Pharmaceuticals Ltd | 65.38 | 15.80 | 0.88% |
Price Comparison
Compare NATCAPSUQ with any stock or ETFShareholdings
Promoter Holdings Trend
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 4.96%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 2.51%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 20, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Jul 20, 2023
Cash Dividend
Ex DateEx DateSep 9, 2022
Dividend/Share
₹1.00
Ex DateEx Date
Sep 9, 2022
Cash Dividend
Ex DateEx DateJul 6, 2021
Dividend/Share
₹1.00
Ex DateEx Date
Jul 6, 2021
Cash Dividend
Ex DateEx DateAug 12, 2020
Dividend/Share
₹0.60
Ex DateEx Date
Aug 12, 2020
Cash Dividend
Ex DateEx DateAug 13, 2019
Dividend/Share
₹1.00
Ex DateEx Date
Aug 13, 2019
Natural Capsules will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
Natural Capsules will hold a meeting of the Board of Directors of the Company on 5 September 2024.Powered by Capital Market - Live
Net profit of Natural Capsules declined 67.03% to Rs 0.60 crore in the quarter ended June 2024 as against Rs 1.82 crore during the previous quarter ended June 2023. Sales rose 3.93% to Rs 39.18 crore in the quarter ended June 2024 as against Rs 37.70 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales39.1837.70 4 OPM %11.1315.81 - PBDT3.054.80 -36 PBT0.772.69 -71 NP0.601.82 -67 Powered by Capital Market - Live
Natural Capsules will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
Natural Capsules announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 23 August 2024 .Powered by Capital Market - Live
Natural Capsules will hold a meeting of the Board of Directors of the Company on 26 July 2024.Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 20.9%, vs industry avg of 9.03%
Increasing Market Share
Over the last 5 years, market share increased from 0.03% to 0.04%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 23.57%, vs industry avg of 15.28%